These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22520745)

  • 1. Targeted therapies for hepatitis C reach the clinic.
    Erdmann J
    Chem Biol; 2012 Apr; 19(4):433-4. PubMed ID: 22520745
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new era in therapy of hepatitis C: "the therapy can now be individualized" (interview by Dr. med. Dirk Einecke)].
    Manns M
    MMW Fortschr Med; 2011 Jul; 153(29-31):17. PubMed ID: 21830729
    [No Abstract]   [Full Text] [Related]  

  • 3. Infectious diseases. First specific drugs raise hopes for hepatitis C.
    Enserink M
    Science; 2011 Apr; 332(6026):159-60. PubMed ID: 21474720
    [No Abstract]   [Full Text] [Related]  

  • 4. [Successful eradication of genotype 4 HCV with telaprevir-based triple antiviral therapy].
    Deneke MG; Dranoff JA; Duarte-Rojo A
    Rev Gastroenterol Mex; 2014; 79(1):64-6. PubMed ID: 24679642
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies with boceprevir].
    MMW Fortschr Med; 2011 Jul; 153(29-31):16. PubMed ID: 21830728
    [No Abstract]   [Full Text] [Related]  

  • 6. Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C.
    Gellad ZF; Reed SD; Muir AJ
    Antivir Ther; 2012; 17(6 Pt B):1189-99. PubMed ID: 23186646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New HCV drugs trigger race for more tolerable therapies.
    Williams SC
    Nat Med; 2011 Dec; 17(12):1526. PubMed ID: 22146431
    [No Abstract]   [Full Text] [Related]  

  • 8. Protease inhibitors in hepatitis C: from chronic disease to cure.
    Iqbal M; McCormick PA
    Ir Med J; 2011 Sep; 104(8):230-1. PubMed ID: 22125874
    [No Abstract]   [Full Text] [Related]  

  • 9. [New times for the treatment of chronic hepatitis C].
    Gerstoft J; Fomsgaard A
    Ugeskr Laeger; 2012 Mar; 174(12):795. PubMed ID: 22433552
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies with telaprevir].
    MMW Fortschr Med; 2011 Jul; 153(29-31):15. PubMed ID: 21830727
    [No Abstract]   [Full Text] [Related]  

  • 11. A major advance in treating hepatitis C.
    Johns Hopkins Med Lett Health After 50; 2011 Dec; 23(10):6. PubMed ID: 22216468
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of hepatitis C in 2011.
    Williams R; Khan AG
    J Ayub Med Coll Abbottabad; 2010; 22(3):1-2. PubMed ID: 22338403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.
    Orlent H; Deltenre P; Francque S; Laleman W; Moreno C; Bourgeois S; Colle I; Delwaide J; De Maeght S; Mulkay JP; Stärkel P; Reynaert H;
    Acta Gastroenterol Belg; 2012 Jun; 75(2):245-59. PubMed ID: 22870791
    [No Abstract]   [Full Text] [Related]  

  • 14. Risky business-the real life of the unresolved HCV therapy.
    Ferreira AO; Marinho RT
    Gastroenterology; 2014 Nov; 147(5):1185-6. PubMed ID: 25263294
    [No Abstract]   [Full Text] [Related]  

  • 15. What about us? Recent advances in the treatment of chronic hepatitis C threaten to leave some parts of the world behind.
    Ahmed F
    J Viral Hepat; 2013 May; 20(5):367-8. PubMed ID: 23565620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral agents and hepatitis C.
    Archer-Festa M; Nilsen-Kupsch S
    N Y State Dent J; 2012; 78(4):42-5. PubMed ID: 23252194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boceprevir.
    Maddur H; Kwo PY
    Hepatology; 2011 Dec; 54(6):2254-7. PubMed ID: 22095684
    [No Abstract]   [Full Text] [Related]  

  • 18. What is the contribution of protease inhibitors to the high mortality of patients with cirrhosis receiving HCV treatment?
    Tovo CV; Mattos AA; Almeida PR
    Gastroenterology; 2014 Nov; 147(5):1185. PubMed ID: 25263302
    [No Abstract]   [Full Text] [Related]  

  • 19. [Future of antiviral therapy for chronic hepatitis C. Direct antiviral acting medications].
    Lange CM; Sarrazin C; Zeuzem S
    Pharm Unserer Zeit; 2011 Jan; 40(1):60-7. PubMed ID: 21194084
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis C genotype 1b and 4 cured after telaprevir-based therapy.
    Pérez-Parente D; Suárez-Ordóñez S; Suárez-Santamaría M; Morano-Amado LE
    Rev Esp Enferm Dig; 2015 Apr; 107(4):251. PubMed ID: 25824935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.